Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Remyelinating the demyelinated CNS.

W F Blakemore1, P M Smith, R J Franklin

  • 1Department of Clinical Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.

Novartis Foundation Symposium
|December 29, 2000
PubMed
Summary

Glial cell transplantation shows promise for remyelinating the central nervous system (CNS) after myelin loss. The most effective approach involves using committed neural precursor cells, though outcomes remain uncertain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skeletal muscle mitochondrial dysfunction is associated with increased Gdf15 expression and circulating GDF15 levels in aged mice.

Scientific reports·2025
Same author

The effect of age and sex on peak oxygen uptake during upper and lower body exercise: A systematic review.

Experimental gerontology·2024
Same author

Exploring the genetics underpinning dynamic laryngeal collapse associated with poll flexion in Norwegian-Swedish Coldblooded Trotter racehorses.

Equine veterinary journal·2019
Same author

A method for securing the temporary lead(s) in sacral nerve stimulation.

Annals of the Royal College of Surgeons of England·2017
Same author

Magnetic resonance imaging findings in epileptic cats with a normal interictal neurological examination: 188 cases.

The Veterinary record·2017
Same author

Examining age differences in duration of wage replacement by injury characteristics.

Occupational medicine (Oxford, England)·2016

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Cell Biology

Background:

  • The central nervous system (CNS) can naturally remyelinate after myelin damage.
  • Persistent demyelination characterizes multiple sclerosis, leucodystrophies, and spinal cord trauma.
  • Current therapeutic strategies focus on enhancing intrinsic repair or cell transplantation.

Purpose of the Study:

  • To review the feasibility of glial cell transplantation for remyelination in the CNS.
  • To address key challenges for human clinical application of glial transplantation.
  • To evaluate the potential of exogenous cell sources for myelin repair.

Main Methods:

  • Review of experimental animal studies on remyelination via cell transplantation.
  • Discussion of safety, cell source, and prediction of remyelination efficacy.
  • Focus on multipotent neural precursor cells committed to oligodendrocyte lineage.

Main Results:

  • Experimental transplantation of myelin-forming cells can remyelinate demyelinated axons.
  • Glial cell transplantation is a potential strategy for chronic demyelination and axon regeneration.
  • Multipotent neural precursor cells committed to oligodendrocyte lineage show significant myelinating potential.

Conclusions:

  • Glial cell transplantation offers a promising therapeutic avenue for demyelinating diseases.
  • The use of committed neural precursor cells is the most viable approach.
  • The extent of remyelination achievable with current methods remains unpredictable.

Related Experiment Videos